TWO SIGMA INVESTMENTS, LP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,573,719
-57.0%
2,341,354
+27.8%
0.05%
-53.5%
Q2 2023$45,516,369
+123.7%
1,832,382
+35.4%
0.11%
+96.6%
Q1 2023$20,347,842
+69.8%
1,352,915
+33.6%
0.06%
+52.6%
Q4 2022$11,983,766
+73.5%
1,012,998
-13.2%
0.04%
+65.2%
Q3 2022$6,906,000
+12.2%
1,166,562
-19.5%
0.02%
+15.0%
Q2 2022$6,155,000
-21.6%
1,448,330
+75.4%
0.02%
-13.0%
Q1 2022$7,853,000
+37.6%
825,771
+597.2%
0.02%
+53.3%
Q1 2021$5,709,000
-52.9%
118,438
-49.1%
0.02%
-57.1%
Q4 2020$12,116,000
+172.6%
232,915
+2.1%
0.04%
+59.1%
Q2 2020$4,445,000
+885.6%
228,191
+462.2%
0.02%
+2100.0%
Q4 2019$451,000
+211.0%
40,590
+56.7%
0.00%
Q3 2019$145,000
-95.4%
25,910
-96.6%
0.00%
-100.0%
Q4 2018$3,153,000
+202.3%
769,011
+312.9%
0.01%
+300.0%
Q3 2018$1,043,000
-15.8%
186,240
+75.2%
0.00%
-25.0%
Q1 2017$1,238,000
+641.3%
106,274
+496.6%
0.00%
+300.0%
Q2 2014$167,000
+263.0%
17,812
+51.4%
0.00%
Q4 2013$46,00011,7650.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders